Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective of PERFECTO is to assess the reendothelialization at 3 months after successfully CTO percutaneous intervention (PCI) with new generation drug eluting stent (DES) by OFDI analysis. Designed as a multicentric, observational and prospective study which will be conducted at University Hospital of Poitiers (France), a systematic OFDI analysis will be realized immediately after CTO-PCI and at 3 months. Known as major predictive factors of stent thrombosis, percentages of malapposition, uncovered struts and neointimal hyperplasia proliferation will be measured over the entire length of each stent implanted combining in a composite primary endpoint.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Successfully CTO recanalization | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Percutaneous recanalization of chronic total occlusion | Procedure | Percutaneous recanalization of chronic total occlusion followed by immediate systematic coronary optical frequency domain imaging (OFDI) at inclusion. Intra-individual post stenting assessment of reendothelialization with a second coronary angiography with OFDI analysis at 3 months. |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of uncovered stent struts | Measured by OFDI 3 months after CTO recanalization every millimeter over entire length of each stent implanted. (Number uncovered struts x 100)/total number of struts. | 3 months |
| Percentage of malapposed stent struts | Measured by OFDI 3 months after CTO recanalization every millimeter over entire length of each stent implanted. (Number of malapposed struts x 100)/total number of struts. | 3 months |
| Percentage of neointimal hyperplasia proliferation | Measured by OFDI 3 months after CTO recanalization every millimeter over entire length of each stent implanted. [(minimal stent area - minimal lumen area)/minimal stent area]x100. | 3 months |
| Minimal lumen area | Measured by OFDI 3 months after CTO recanalization every millimeter over entire length of each stent implanted. | 3 months |
| Minimal lumen diameter | Measured by OFDI 3 months after CTO recanalization every millimeter over entire length of each stent implanted | 3 months |
| Thrombus | Measured by OFDI 3 months after CTO recanalization every millimeter over entire length of each stent implanted. | 3 months |
| Edge dissection | Measured by OFDI 3 months after CTO recanalization every millimeter over entire length of each stent implanted. |
| Measure | Description | Time Frame |
|---|---|---|
| Relevancy of immediate post-PCI OFDI analysis | To estimate the percentage of patients in whom the post-stenting OFDI analysis will reveal a suboptimal result of angioplasty whereas final angiography was considered optimal, as assessed by the presence of one or more of the following criteria:
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sebastien Levesque, MD | University Hospital of Poitiers, Department of Cardiology | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHU de Clermont-Ferrand | Clermont-Ferrand | 63000 | France | |||
| GHM de Grenoble |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 40930013 | Derived | Levesque S, Faurie B, Lattuca B, Lemoine J, Pitchecanin G, Motreff P, Bressollette E, Ragot S, Bouleti C, Christiaens LP. Optical Coherence Tomography to Better Assess Chronic Total Occlusion Percutaneous Intervention Results: The PERFECTO Study. JACC Adv. 2025 Oct;4(10 Pt 2):102125. doi: 10.1016/j.jacadv.2025.102125. Epub 2025 Sep 9. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 3 months |
| Day one |
| Impact of the technique employed for CTO revascularization on the reendothelialization | Comparison of primary composite endpoint between different way of recanalization:
| 3 months |
| One year clinical follow-up | Each participating center will perform one year after CTO PCI a clinical evaluation of all patients included. This could be established directly with the subject during medical follow-up or indirectly via family doctor. Standardized questionnaire will be provided at the end of the e-case report form (CRF). Occurrence of major adverse cardiac events (myocardial infarction, death, stroke), sudden death, hospitalization for cardiac disease and severe hemorrhage will be recorded. Any new coronary arteriography will be noticed, as well as any PCI or coronary artery bypass graft (CABG) during this one-year follow-up.
| One year |
| Angina | About symptoms, the Canadian Cardiovascular Society (CCS) grading system and New York Heart Association functional classification will be used to assess respectively exertion-induced angina and dyspnea, and compared to symptoms recorded before CTO revascularization. | One year |
| Dyspnea | About symptoms, the Canadian Cardiovascular Society (CCS) grading system and New York Heart Association functional classification will be used to assess respectively exertion-induced angina and dyspnea, and compared to symptoms recorded before CTO revascularization. | One year |
| Grenoble |
| 38000 |
| France |
| Bressollette | Nantes | France |
| CHU de Nimes | Nîmes | 30000 | France |
| CHU Poitiers | Poitiers | 86021 | France |
| Institut A.Tzanck | Saint-Laurent-du-Var | 06000 | France |
| CHU de Toulouse | Toulouse | 31000 | France |